CQS Cayman’s BeOne Medicines Ltd ONC Stock Holding History

CQS Cayman’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-73,358	Closed	-$2.26M	–	137
2016 Q3	$2.26M	Sell	73,358 -1,000	-1%	-$29K	0.19%	76
2016 Q2	$2.22M	Buy	+74,358	New	+$2.18M	0.2%	83

Other funds holding ONC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

CQS Cayman's ONC Position: Q4 2016 in Review

CQS Cayman sold out of BeOne Medicines Ltd (ONC) in Q4 2016, closing a stake of 73,358 shares — an estimated $2.26M sold.

CQS Cayman first reported a position in ONC in Q2 2016 and held it in 2 quarters. The position peaked at $2.26M in Q3 2016. 54 funds tracked by Wall St. Rank hold ONC as of Q4 2016.

CQS Cayman reported no remaining BeOne Medicines Ltd position as of Q4 2016 after selling out during the quarter.
CQS Cayman sold 73,358 BeOne Medicines Ltd shares in Q4 2016, an estimated $2.26M.
CQS Cayman first reported a position in BeOne Medicines Ltd in Q2 2016 and held it in 2 quarters.
CQS Cayman's BeOne Medicines Ltd position peaked at $2.26M in Q3 2016.
54 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2016.

Based on CQS Cayman's 13F filing for Q4 2016, filed 14 Feb 2017.